Publicaciones en las que colabora con Mario Delgado Mora (84)

2024

  1. Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 2

2023

  1. Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Efficacy of Vafidemstat in Experimental Autoimmune Encepha-Lomyelitis Highlights the KDM1A/RCOR1/HDAC Epigenetic Axis in Multiple Sclerosis

    Pharmaceutics, Vol. 14, Núm. 7

  2. Robust in Vitro and in Vivo Immunosuppressive and Anti-inflammatory Properties of Inducible Caspase-9-mediated Apoptotic Mesenchymal Stromal/Stem Cell

    Stem Cells Translational Medicine, Vol. 11, Núm. 1, pp. 88-96

  3. Switching Roles: Beneficial Effects of Adipose Tissue-Derived Mesenchymal Stem Cells on Microglia and Their Implication in Neurodegenerative Diseases

    Biomolecules, Vol. 12, Núm. 2

2021

  1. Silyl resveratrol derivatives as potential therapeutic agents for neurodegenerative and neurological diseases

    European Journal of Medicinal Chemistry, Vol. 223

  2. Structure-based design of a Cortistatin analogue with immunomodulatory activity in models of inflammatory bowel disease

    Nature Communications, Vol. 12, Núm. 1

  3. The neuropeptide cortistatin alleviates neuropathic pain in experimental models of peripheral nerve injury

    Pharmaceutics, Vol. 13, Núm. 7

2019

  1. Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis

    Haematologica, Vol. 104, Núm. 2, pp. e54-e58

2018

  1. Alkylated resveratrol prodrugs and metabolites as potential therapeutics for neurodegenerative diseases

    European Journal of Medicinal Chemistry, Vol. 146, pp. 123-138

  2. Vasoactive intestinal peptide ameliorates acute myocarditis and atherosclerosis by regulating inflammatory and autoimmune responses

    Journal of Immunology, Vol. 200, Núm. 11, pp. 3697-3710

2017

  1. Allogeneic adipose-derived mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by regulating self-reactive T cell responses and dendritic cell function

    Stem Cells International, Vol. 2017

  2. Cortistatin reduces atherosclerosis in hyperlipidemic ApoE-deficient mice and the formation of foam cells

    Scientific Reports, Vol. 7

  3. Ghrelin and adipose-derived mesenchymal stromal cells improve nerve regeneration in a rat model of epsilon-caprolactone conduit reconstruction

    Histology and Histopathology, Vol. 32, Núm. 6, pp. 627-637

  4. Role of Cortistatin in the Stressed Immune System

    Frontiers of Hormone Research, Vol. 48, pp. 110-120

  5. Role of Cortistatin in the Stressed Immune System

    Frontiers of hormone research, Vol. 48, pp. 110-120

  6. The neuropeptide cortistatin attenuates experimental autoimmune myocarditis via inhibition of cardiomyogenic T cell-driven inflammatory responses

    British Journal of Pharmacology, Vol. 174, Núm. 3, pp. 267-280

  7. Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease

    Experimental & molecular medicine, Vol. 49, Núm. 2, pp. e290

2015

  1. Lulling immunity, pain, and stress to sleep with cortistatin

    Annals of the New York Academy of Sciences, Vol. 1351, Núm. 1, pp. 89-98

  2. Osteoarticular Expression of Musashi-1 in an Experimental Model of Arthritis

    BioMed Research International, Vol. 2015